title: [Effect of suppletory estrogen or 1,25(OH)D3 on bone mineral content].
abstract: Post-menopausal changes in bone mineral content (BMC) and the effect of suppletory estrogen or 1,25(OH)D3 was studied. BMC was evaluated by means of quantitative computed tomography. Post-menopausal BMC (age 45-49) was 158.4 +/- 42.0 mg/cm3 which was significantly lower than in other subjects in the same aged group (192.3 +/- 27.1 mg/cm3). At two years, ten years and more than ten years post-menopause it decreased significantly by 17%, 30%, 55% respectively, compared with that of pre-menopausal BMC. The administration of conjugated estrogen (0.625 mg) or 1,25(OH)D3 was effective in preventing bone loss, although a transient decrease in BMC was observed in some cases to which 1,25(OH)D3 was administered. In cases of pre-menopausal bilateral oophorectomy, BMC was found to decrease significantly to the post-menopausal level about two years after operation. However, long-term estrogen replacement therapy tends to inhibit the decrease.
authors.affiliation: Department of Obstetrics and Gynecology, Kitasato University School of Medicine, Kanagawa.
authors.forename: K
authors.initials: K
authors.lastname: Amano
authors.forename: R
authors.initials: R
authors.lastname: Nemoto
authors.forename: Y
authors.initials: Y
authors.lastname: Kato
authors.forename: R
authors.initials: R
authors.lastname: Masuda
authors.forename: M
authors.initials: M
authors.lastname: Nishijima
mesh_terms: D000368:Aged; D000375:Aging / Q000378:metabolism*; D015519:Bone Density / Q000187:drug effects*; D002117:Calcitriol / Q000008:administration & dosage / Q000494:pharmacology*; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D008593:Menopause / Q000378:metabolism; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control; D010052:Ovariectomy
chemical_list: D002117:Calcitriol